These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 11789676

  • 1. Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents.
    Szebeni J.
    Crit Rev Ther Drug Carrier Syst; 2001; 18(6):567-606. PubMed ID: 11789676
    [Abstract] [Full Text] [Related]

  • 2. Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity.
    Szebeni J.
    Toxicology; 2005 Dec 15; 216(2-3):106-21. PubMed ID: 16140450
    [Abstract] [Full Text] [Related]

  • 3. Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention.
    Szebeni J, Muggia F, Gabizon A, Barenholz Y.
    Adv Drug Deliv Rev; 2011 Sep 16; 63(12):1020-30. PubMed ID: 21787819
    [Abstract] [Full Text] [Related]

  • 4. Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals.
    Szebeni J.
    Mol Immunol; 2014 Oct 16; 61(2):163-73. PubMed ID: 25124145
    [Abstract] [Full Text] [Related]

  • 5. A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines.
    Szebeni J, Bedőcs P, Csukás D, Rosivall L, Bünger R, Urbanics R.
    Adv Drug Deliv Rev; 2012 Dec 16; 64(15):1706-16. PubMed ID: 22820530
    [Abstract] [Full Text] [Related]

  • 6. Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs.
    Szebeni J, Storm G.
    Biochem Biophys Res Commun; 2015 Dec 18; 468(3):490-7. PubMed ID: 26182876
    [Abstract] [Full Text] [Related]

  • 7. Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses.
    Dézsi L, Fülöp T, Mészáros T, Szénási G, Urbanics R, Vázsonyi C, Őrfi E, Rosivall L, Nemes R, Kok RJ, Metselaar JM, Storm G, Szebeni J.
    J Control Release; 2014 Dec 10; 195():2-10. PubMed ID: 25148822
    [Abstract] [Full Text] [Related]

  • 8. Factor H inhibits complement activation induced by liposomal and micellar drugs and the therapeutic antibody rituximab in vitro.
    Mészáros T, Csincsi ÁI, Uzonyi B, Hebecker M, Fülöp TG, Erdei A, Szebeni J, Józsi M.
    Nanomedicine; 2016 May 10; 12(4):1023-1031. PubMed ID: 26733258
    [Abstract] [Full Text] [Related]

  • 9. The interaction of liposomes with the complement system.
    Szebeni J.
    Crit Rev Ther Drug Carrier Syst; 1998 May 10; 15(1):57-88. PubMed ID: 9523086
    [Abstract] [Full Text] [Related]

  • 10. Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles.
    Szebeni J, Alving CR, Rosivall L, Bünger R, Baranyi L, Bedöcs P, Tóth M, Barenholz Y.
    J Liposome Res; 2007 May 10; 17(2):107-17. PubMed ID: 17613700
    [Abstract] [Full Text] [Related]

  • 11. Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction.
    Szebeni J, Baranyi L, Savay S, Bodo M, Morse DS, Basta M, Stahl GL, Bünger R, Alving CR.
    Am J Physiol Heart Circ Physiol; 2000 Sep 10; 279(3):H1319-28. PubMed ID: 10993799
    [Abstract] [Full Text] [Related]

  • 12. Prevention of infusion reactions to PEGylated liposomal doxorubicin via tachyphylaxis induction by placebo vesicles: a porcine model.
    Szebeni J, Bedőcs P, Urbanics R, Bünger R, Rosivall L, Tóth M, Barenholz Y.
    J Control Release; 2012 Jun 10; 160(2):382-7. PubMed ID: 22421426
    [Abstract] [Full Text] [Related]

  • 13. Complement activation-related pseudoallergy caused by amphiphilic drug carriers: the role of lipoproteins.
    Szebeni J.
    Curr Drug Deliv; 2005 Oct 10; 2(4):443-9. PubMed ID: 16305447
    [Abstract] [Full Text] [Related]

  • 14. Methylation of the phosphate oxygen moiety of phospholipid-methoxy(polyethylene glycol) conjugate prevents PEGylated liposome-mediated complement activation and anaphylatoxin production.
    Moghimi SM, Hamad I, Andresen TL, Jørgensen K, Szebeni J.
    FASEB J; 2006 Dec 10; 20(14):2591-3. PubMed ID: 17065229
    [Abstract] [Full Text] [Related]

  • 15. Immediate and delayed reactions to radiocontrast media: is there an allergic mechanism?
    Brockow K.
    Immunol Allergy Clin North Am; 2009 Aug 10; 29(3):453-68. PubMed ID: 19563991
    [Abstract] [Full Text] [Related]

  • 16. In vivo applications of PEG liposomes: unexpected observations.
    Laverman P, Boerman OC, Oyen WJG, Corstens FHM, Storm G.
    Crit Rev Ther Drug Carrier Syst; 2001 Aug 10; 18(6):551-66. PubMed ID: 11789675
    [Abstract] [Full Text] [Related]

  • 17. Allergy-like reactions to iodinated contrast agents. A critical analysis.
    Idée JM, Pinès E, Prigent P, Corot C.
    Fundam Clin Pharmacol; 2005 Jun 10; 19(3):263-81. PubMed ID: 15910651
    [Abstract] [Full Text] [Related]

  • 18. Involvement of complement activation in the pulmonary vasoactivity of polystyrene nanoparticles in pigs: unique surface properties underlying alternative pathway activation and instant opsonization.
    Mészáros T, Kozma GT, Shimizu T, Miyahara K, Turjeman K, Ishida T, Barenholz Y, Urbanics R, Szebeni J.
    Int J Nanomedicine; 2018 Jun 10; 13():6345-6357. PubMed ID: 30349254
    [Abstract] [Full Text] [Related]

  • 19. Adverse drug reactions: types and treatment options.
    Riedl MA, Casillas AM.
    Am Fam Physician; 2003 Nov 01; 68(9):1781-90. PubMed ID: 14620598
    [Abstract] [Full Text] [Related]

  • 20. Complement Activation-Related Pathophysiological Changes in Anesthetized Rats: Activator-Dependent Variations of Symptoms and Mediators of Pseudoallergy.
    Dézsi L, Mészáros T, Őrfi E, Fülöp TG, Hennies M, Rosivall L, Hamar P, Szebeni J, Szénási G.
    Molecules; 2019 Sep 09; 24(18):. PubMed ID: 31505853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.